Cargando…
复发白血病异基因造血干细胞移植后疗效的改进策略
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348243/ https://www.ncbi.nlm.nih.gov/pubmed/28954358 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.018 |
_version_ | 1783556760581177344 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7348243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73482432020-07-16 复发白血病异基因造血干细胞移植后疗效的改进策略 Zhonghua Xue Ye Xue Za Zhi 综述 Editorial office of Chinese Journal of Hematology 2017-08 /pmc/articles/PMC7348243/ /pubmed/28954358 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.018 Text en 2017年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 综述 复发白血病异基因造血干细胞移植后疗效的改进策略 |
title | 复发白血病异基因造血干细胞移植后疗效的改进策略 |
title_full | 复发白血病异基因造血干细胞移植后疗效的改进策略 |
title_fullStr | 复发白血病异基因造血干细胞移植后疗效的改进策略 |
title_full_unstemmed | 复发白血病异基因造血干细胞移植后疗效的改进策略 |
title_short | 复发白血病异基因造血干细胞移植后疗效的改进策略 |
title_sort | 复发白血病异基因造血干细胞移植后疗效的改进策略 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348243/ https://www.ncbi.nlm.nih.gov/pubmed/28954358 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.018 |
work_keys_str_mv | AT fùfābáixuèbìngyìjīyīnzàoxuègànxìbāoyízhíhòuliáoxiàodegǎijìncèlüè AT fùfābáixuèbìngyìjīyīnzàoxuègànxìbāoyízhíhòuliáoxiàodegǎijìncèlüè |